138 related articles for article (PubMed ID: 30943030)
1. Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
Sharma S; Hopkins CR
J Med Chem; 2019 Sep; 62(17):7589-7602. PubMed ID: 30943030
[TBL] [Abstract][Full Text] [Related]
2. TRPC1 as a negative regulator for TRPC4 and TRPC5 channels.
Kim J; Ko J; Myeong J; Kwak M; Hong C; So I
Pflugers Arch; 2019 Aug; 471(8):1045-1053. PubMed ID: 31222490
[TBL] [Abstract][Full Text] [Related]
3. Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials.
Gao YY; Tian W; Zhang HN; Sun Y; Meng JR; Cao W; Li XQ
Arch Pharm Res; 2021 Apr; 44(4):354-377. PubMed ID: 33763843
[TBL] [Abstract][Full Text] [Related]
4. Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5.
Richter JM; Schaefer M; Hill K
Mol Pharmacol; 2014 Nov; 86(5):514-21. PubMed ID: 25140002
[TBL] [Abstract][Full Text] [Related]
5. The interaction domains of transient receptor potential canonical (TRPC)1/4 and TRPC1/5 heteromultimeric channels.
Myeong J; Ko J; Hong C; Yang D; Lee KP; Jeon JH; So I
Biochem Biophys Res Commun; 2016 Jun; 474(3):476-481. PubMed ID: 27131740
[TBL] [Abstract][Full Text] [Related]
6. Treasure troves of pharmacological tools to study transient receptor potential canonical 1/4/5 channels.
Rubaiy HN
Br J Pharmacol; 2019 Apr; 176(7):832-846. PubMed ID: 30656647
[TBL] [Abstract][Full Text] [Related]
7. Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure.
Xu SZ; Zeng B; Daskoulidou N; Chen GL; Atkin SL; Lukhele B
Toxicol Sci; 2012 Jan; 125(1):56-68. PubMed ID: 21984481
[TBL] [Abstract][Full Text] [Related]
8. Discovery of pyrroledione analogs as potent transient receptor potential canonical channel 5 inhibitors.
Zhang Z; Chen L; Tian H; Liu M; Jiang S; Shen J; Wang K; Cao Z
Bioorg Med Chem Lett; 2022 Apr; 61():128612. PubMed ID: 35143983
[TBL] [Abstract][Full Text] [Related]
9. Targeting Transient Receptor Potential Canonical Channels for Diseases of the Nervous System.
Wang Y; Bu J; Shen H; Li H; Wang Z; Chen G
Curr Drug Targets; 2017; 18(12):1460-1465. PubMed ID: 26648074
[TBL] [Abstract][Full Text] [Related]
10. A benzothiadiazine derivative and methylprednisolone are novel and selective activators of transient receptor potential canonical 5 (TRPC5) channels.
Beckmann H; Richter J; Hill K; Urban N; Lemoine H; Schaefer M
Cell Calcium; 2017 Sep; 66():10-18. PubMed ID: 28807145
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of TRPC Channels and Its Potential in Cardiovascular and Metabolic Medicine.
Bon RS; Wright DJ; Beech DJ; Sukumar P
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():427-446. PubMed ID: 34499525
[TBL] [Abstract][Full Text] [Related]
12. Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain.
Fowler MA; Sidiropoulou K; Ozkan ED; Phillips CW; Cooper DC
PLoS One; 2007 Jun; 2(6):e573. PubMed ID: 17593972
[TBL] [Abstract][Full Text] [Related]
13. Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels.
Maier T; Follmann M; Hessler G; Kleemann HW; Hachtel S; Fuchs B; Weissmann N; Linz W; Schmidt T; Löhn M; Schroeter K; Wang L; Rütten H; Strübing C
Br J Pharmacol; 2015 Jul; 172(14):3650-60. PubMed ID: 25847402
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.
Sharma SH; Pablo JL; Montesinos MS; Greka A; Hopkins CR
Bioorg Med Chem Lett; 2019 Jan; 29(2):155-159. PubMed ID: 30538066
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the cellular localization and function of human transient receptor potential channel 1 by other members of the TRPC family.
Alfonso S; Benito O; Alicia S; Angélica Z; Patricia G; Diana K; Vaca L
Cell Calcium; 2008 Apr; 43(4):375-87. PubMed ID: 17850866
[TBL] [Abstract][Full Text] [Related]
16. Cryo-EM structure of TRPC5 at 2.8-Å resolution reveals unique and conserved structural elements essential for channel function.
Duan J; Li J; Chen GL; Ge Y; Liu J; Xie K; Peng X; Zhou W; Zhong J; Zhang Y; Xu J; Xue C; Liang B; Zhu L; Liu W; Zhang C; Tian XL; Wang J; Clapham DE; Zeng B; Li Z; Zhang J
Sci Adv; 2019 Jul; 5(7):eaaw7935. PubMed ID: 31355338
[TBL] [Abstract][Full Text] [Related]
17. Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels.
Zhu Y; Lu Y; Qu C; Miller M; Tian J; Thakur DP; Zhu J; Deng Z; Hu X; Wu M; McManus OB; Li M; Hong X; Zhu MX; Luo HR
Br J Pharmacol; 2015 Jul; 172(14):3495-509. PubMed ID: 25816897
[TBL] [Abstract][Full Text] [Related]
18. Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice.
Just S; Chenard BL; Ceci A; Strassmaier T; Chong JA; Blair NT; Gallaschun RJ; Del Camino D; Cantin S; D'Amours M; Eickmeier C; Fanger CM; Hecker C; Hessler DP; Hengerer B; Kroker KS; Malekiani S; Mihalek R; McLaughlin J; Rast G; Witek J; Sauer A; Pryce CR; Moran MM
PLoS One; 2018; 13(1):e0191225. PubMed ID: 29385160
[TBL] [Abstract][Full Text] [Related]
19. Plasma membrane insertion of TRPC5 channels contributes to the cholinergic plateau potential in hippocampal CA1 pyramidal neurons.
Tai C; Hines DJ; Choi HB; MacVicar BA
Hippocampus; 2011 Sep; 21(9):958-67. PubMed ID: 20865744
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.
Chen L; Zhang Z; Tian H; Jiang S; Ji Y; Liu M; Shen J; Cao Z; Wang K
Bioorg Med Chem; 2022 Aug; 68():116853. PubMed ID: 35653869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
